What is it about?
This case study explores how a 71-year-old cancer patient undergoing 18F-FDG PET/CT scans for renal carcinoma staging was incidentally found to have giant cell arteritis. The study evaluates aortic uptake in PET/CT scans to identify significant co-morbidities in cancer patients.
Featured Image
Photo by Accuray on Unsplash
Why is it important?
The article highlights a critical issue in cancer care: the potential for overlooking other serious conditions. It shows PET/CT scans can serve a dual purpose—cancer staging and identifying co-morbidities like giant cell arteritis. This could lead to more comprehensive patient care and better outcomes.
Perspectives
This publication is a wake-up call for clinicians. It's not just about the cancer; it's about the whole patient. The case study shows how a routine scan for one condition can reveal another potentially life-threatening one. It's a compelling argument for a more holistic approach to interpreting PET/CT scans, which could significantly impact patient care.
Thomas F Heston MD
University of Washington
Read the Original
This page is a summary of: Giant cell arteritis on 18F-FDG PET/CT, Clinical Physiology and Functional Imaging, September 2009, Wiley,
DOI: 10.1111/j.1475-097x.2009.00881.x.
You can read the full text:
Resources
Contributors
The following have contributed to this page
